Globus Medical (GMED) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $0.88.
- Globus Medical's EPS (Weighted Average and Diluted) rose 13157.89% to $0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1, marking a year-over-year increase of 37692.31%. This contributed to the annual value of $0.75 for FY2024, which is 2990.65% down from last year.
- Globus Medical's EPS (Weighted Average and Diluted) amounted to $0.88 in Q3 2025, which was up 13157.89% from $1.49 recorded in Q2 2025.
- Globus Medical's 5-year EPS (Weighted Average and Diluted) high stood at $1.49 for Q2 2025, and its period low was -$0.05 during Q1 2024.
- For the 5-year period, Globus Medical's EPS (Weighted Average and Diluted) averaged around $0.43, with its median value being $0.44 (2021).
- Within the past 5 years, the most significant YoY rise in Globus Medical's EPS (Weighted Average and Diluted) was 370000.0% (2024), while the steepest drop was 11041.67% (2024).
- Over the past 5 years, Globus Medical's EPS (Weighted Average and Diluted) (Quarter) stood at $0.14 in 2021, then surged by 250.0% to $0.49 in 2022, then tumbled by 81.63% to $0.09 in 2023, then skyrocketed by 111.11% to $0.19 in 2024, then soared by 363.16% to $0.88 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.88 in Q3 2025, compared to $1.49 in Q2 2025 and $0.54 in Q1 2025.